2KEILSON L, MATHER S, WAOTER YH, et al. Synergistic effects of nateglinide and meal administration on insulin secretion inpatients with type 2 diabetes mellitus [ J ]. J Clin Endocrinol Metab 2000;85(3) : 1081 - 1086.
3HU S, WANG S, FANELL I B, et al. Pancreatic beta - cell K(ATP) channel activity and membrane- binding studies with nateglinide: a comparison with salfonylureas and repaglinide[ J ]. J Pharmacol Exp Ther 2000 ; 293 (2) : 444 - 452,
4de SOUZA CL, GAGEN K, CHENW, et al. Early insulin release effectively improves glucose tolerance: studies in two rodentmodels of type 2 diabetes mellitus[J]. Diabetes Obes Metab 2001;3(2): 85- 95,
5CARROLL MF, IZARD A, B IBON I K, et al, Control of postp randial hyperglycemia: optimal use of short - acting insulin secretagogues[J].Diabetes Care 2002;25(12):214722150.
6KALBAG J, H IRSCHBERG Y, MCLEOD JF, et al. Comparison of mealtime glucose regulation by nateglinide and repaglinide in healthy subjects[J].Diabetes 1999;48 Suppl 1:A106.